CERo Therapeutics Holdings, Inc. ( CERO) - Key Metrics
CERO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.02 | -$0.06 | -$0.06 |
| 2026Q1 | $0 | -$0.20 | -$0.10 | -$0.10 |
| 2025Q4 | $0 | -$1.07 | -$0.90 | -$0.90 |
| 2025Q3 | $0 | -$3.84 | -$2.53 | -$2.53 |
| 2025Q2 | $0 | -$11.10 | -$9.47 | -$9.47 |
CERO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.00 |
| 2026Q1 | 0% | -0.04 |
| 2025Q4 | 0% | -0.01 |
| 2025Q3 | 0% | -0.14 |
| 2025Q2 | 0% | -0.04 |
CERO
Price: $0.01
52 week price:
Earnings Per Share: 84.10 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 496236